Bio-Techne Diagnostics at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Bio-Techne Diagnostics at ASHG 2026 in Montréal: Booth 1524.

Organization

ASHG 2026 Attendance

Bio-Techne Diagnostics

Austin, Texas

bio-technediagnostics.com|LinkedIn

Public company~3,000 people

Bio-Techne Diagnostics sells molecular diagnostic kits, quality controls, and IVD reagents. It serves clinical laboratories, assay developers, and diagnostic manufacturers.

Agreed to be acquired by Merck KGaA for $73 per share, a deal folding it into a larger life-science conglomerate.

›

Agreed to be acquired by Merck KGaA for $73 per share, a deal folding it into a larger life-science conglomerate.

2026-06 · source

Partnered with Refeyn on an integrated workflow for characterizing bispecific antibodies and biosimilars, a new offering for biologics developers.

2026-06 · source

Reorganized its products under three brands, including a new standalone Bio-Techne Diagnostics brand, clarifying how customers navigate its diagnostics line.

2026-04 · source

Source: company newsroom

Q4 FY2026 revenue $321.2M, up 1% reported

›

Organic growth was 3%; the pending Merck KGaA acquisition may affect future reporting. · 2026-08-12

“Net sales for the fourth quarter increased 1% to $321.2 million. Organic growth increased 3% compared to the prior year.”

Source: results release

Currently hiring

›

Source: careers page

Booth

Exhibiting at Booth 1524

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Instantly find 20 buyers from Bio-Techne Diagnostics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction